Synthesis and Cytotoxic Activity of (4-Substituted-benzylidene)-(3-Phenyl-1,2,4-Oxadiazol-5-YL)Methylamines

被引:0
作者
K. Kucukoglu
M. Tugrak
A. Demirtas
H. Sakagami
H. I. Gul
机构
[1] Ataturk University,Department of Pharmaceutical Chemistry, Faculty of Pharmacy
[2] Meikai University,Division of Pharmacology, School of Dentistry
来源
Pharmaceutical Chemistry Journal | 2016年 / 50卷
关键词
1,2,4-oxadiazole; Gabriel synthesis; Schiff base; cytotoxicity;
D O I
暂无
中图分类号
学科分类号
摘要
This work was aimed at the synthesis and investigation of the cytotoxic activity of a series of Schiff bases having (4-substituted-benzylidene)-(3-phenyl-1,2,4-oxadiazol-5-yl)methylamine structure with different electronic natures of substituents in the phenyl ring. Thus, the study was intended to observe the effect of substituents with different electronic properties on the cytotoxic activity. The synthesized series of compounds (OP) were obtained by six-step synthesis with yields ranging from 12.23 to 25.77%. The chemical structures of these compounds were elucidated by H NMR. The cytotoxicity of compounds against human oral squamous cell carcinoma cell lines [Ca9-22 (gum), HSC-2 (mouth), HSC-3 (fluent), HSC-4 (language)] and human oral normal cells [HGF (gum fibroblasts), HPC (pulp cells), and HPLF (periodontal ligament fibroblasts)] was tested by MTT assay. Among the group of six OP compounds, bromo derivative OP2, non-substituted derivative OP1, and chloro derivative OP3 showed higher cytotoxicity (2.71-, 1.56-, and 1.53-fold, respectively) than the reference compound 5-FU. In addition, OP2 (3.27) exhibited the greatest selectivity index in this group. These compounds can be considered to be model structures for further studies.
引用
收藏
页码:234 / 238
页数:4
相关论文
共 65 条
  • [1] Shaw SJ(2008)undefined Mini Rev. Med. Chem. 8 276-284
  • [2] Varmus H(2006)undefined Science 312 1162-1165
  • [3] Harrison MR(2009)undefined Clin. Adv. Hematol. Oncol. 7 54-64
  • [4] Holen KD(1994)undefined J. Med. Chem. 37 2421-2436
  • [5] Liu G(2011)undefined J. Chem. Pharm. Res. 3 496-505
  • [6] Diana GD(1980)undefined J. Med. Chem. 23 690-692
  • [7] Volkots DL(2007)undefined Eur. J. Med. Chem. 42 873-879
  • [8] Nitz TJ(2005)undefined J. Med. Chem. 48 5215-5223
  • [9] Tale RH(2009)undefined Bioorg. Med. Chem. Lett. 19 2739-2741
  • [10] Rodge AH(2011)undefined Eur. J. Med. Chem. 46 3085-3092